ANEB
AnebuloยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ANEB Profile
Anebulo Pharmaceuticals, Inc.
A clinical-stage biopharmaceutical company that developing novel solutions for acute cannabinoid intoxication and substance abuse
1017 Ranch Road 620 South, Suite 107, Lakeway, Texas 78734
--
Anebulo Pharmaceuticals, Inc., was incorporated in Delaware on April 23, 2020. They are a clinical-stage biotechnology company developing treatments for cannabis toxicity such as unintentional cannabis poisoning, acute cannabinoid poisoning (" ACI ") and broader acute cannabinoid-induced diseases. Their lead product candidate, selonabant (formerly ANEB-001), is designed to rapidly reverse the negative effects of cannabis toxicity and shorten recovery time.
